TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
2.690
+0.030 (1.13%)
Jan 17, 2025, 4:00 PM EST - Market closed
TELA Bio Revenue
TELA Bio had revenue of $18.96M in the quarter ending September 30, 2024, with 25.94% growth. This brings the company's revenue in the last twelve months to $68.65M, up 29.34% year-over-year. In the year 2023, TELA Bio had annual revenue of $58.45M with 41.13% growth.
Revenue (ttm)
$68.65M
Revenue Growth
+29.34%
P/S Ratio
0.96
Revenue / Employee
$302,419
Employees
227
Market Cap
105.95M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
TELA News
- 5 weeks ago - TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - TELA Bio to Participate in Piper Sandler's 36th Annual Healthcare Conference - GlobeNewsWire
- 2 months ago - TELA Bio, Inc. (TELA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 3 months ago - TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 3 months ago - TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 3 months ago - TELA Bio to Announce Third Quarter 2024 Financial Results - GlobeNewsWire
- 5 months ago - TELA Bio, Inc. (TELA) Q2 2024 Earnings Call Transcript - Seeking Alpha